LEXICON PHARMACEUTICALS, INC. (LXRX) Net margin 2017–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-101.1%FY2025 · since FY2017: -774.0% → -101.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -101.1% | +3238.4 pp |
| FY2024 | -3339.5% | +12617.2 pp |
| FY2023 | -15956.7% | — |
| FY2020 | -250.3% | -652.8 pp |
| FY2019 | 402.5% | +856.0 pp |
| FY2018 | -453.5% | +320.5 pp |
| FY2017 | -774.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net incomeLXRX Gross profitLXRX Gross marginLXRX Operating incomeLXRX Operating marginLXRX Operating cash flowLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →